ABIOMED (ABMD)
ABIOMED Key Statistics
Pro Data ExportCurrent Valuation
| Market Cap | 810.99M * |
| Enterprise Value | 797.16M |
| PE Ratio | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Sales Ratio | 6.418 * |
| Price / Book Value | 6.422 * |
| EV / Revenues Pro | Go Pro |
| EV / EBITDA Pro | Go Pro |
| EV / EBIT Pro | Go Pro |
| Operating Earnings Yield Pro | Go Pro * |
Dividends and Shares
| Dividend | |
| Dividend Yield | 0.00% * |
| Cash Div. Payout Ratio TTM Pro | Go Pro |
| Payout Ratio TTM Pro | Go Pro * |
| Dividend Date | |
| Ex-Dividend Date | |
| Last Split Factor | |
| Last Split Date |
Profitability
| Gross Profit Margin | 81.84% * |
| EBITDA Margin TTM Pro | Go Pro * |
| Operating Margin TTM Pro | Go Pro * |
| Profit Margin | 6.86% * |
Management Effectiveness
| Asset Utilization | 0.8867 * |
| Days Sales Outstanding Pro | Go Pro * |
| Days Inventory Outstanding Pro | Go Pro * |
| Days Payable Outstanding Pro | Go Pro * |
| Receivables Turnover | 7.598 * |
| Return on Equity | 1.30% * |
| Return on Assets | 1.08% * |
| Return on Invested Capital Pro | Go Pro * |
Liquidity and Solvency
| Altman Z-Score Pro | Go Pro * |
| Current Ratio | 4.932 * |
| Debt to Equity Ratio | 0.00 * |
| KZ Index Pro | Go Pro * |
| Tangible Common Equity Ratio Pro | Go Pro * |
| Times Interest Earned TTM Pro | Go Pro |
Stock Price Performance
| Beta Pro | Go Pro |
| 1 Month Stock Returns | -14.75% |
| Year to Date Stock Returns | 12.62% |
| 1 Year Stock Returns | 9.82% |
| 3 Year Stock Returns | 248.4% |
| 52 Week High | 26.17 |
| 52 Week Low | 9.98 |
Income Statement
| Revenues TTM | 126.37M * |
| Revenue Per Share TTM | 3.241 * |
| Revenue Growth | 30.88% * |
| Gross Profit TTM | 101.87M * |
| EBITDA TTM Pro | Go Pro * |
| Income from Cont. Ops Pro | Go Pro * |
| Net Income TTM | 1.49M * |
| Earnings Per Share TTM | -0.08 |
| Other Comprehensive Income Pro | Go Pro |
Cash Flow Statement
| Cash Investing TTM | 0.00 * |
| Cash Financing TTM | 0.00 * |
| Cash Operations TTM | 0.00 * |
| Capital Expenditures | 0.80M |
Share Statistics
| Shares Outstanding | 38.99M * |
Balance Sheet
| Cash and ST Investments | 77.22M * |
| Total Assets | 153.91M * |
| Liabilities | 22.41M * |
| Book Value | 126.29M * |
| Book Value per Share | 3.239 * |
| Tangible Book Value Pro | Go Pro * |
| Tangible Book Value Per Share Pro | Go Pro * |
| Long Term Debt | 0.00 * |
Earnings Quality
| Accruals Pro | Go Pro * |
| Beneish M-Score Pro | Go Pro |
Key stats for ABMD are based on the quarter ending Dec. 31, 2011. Asterisk (*) indicates value is based on preliminary data. Preliminary key stats for ABMD are based on the quarter ending March 31, 2012. When preliminary data is not available for all parts of a calculation, we use non-preliminary data for all parts of that calculation.
You may also be interested in these ABMD related companies
ABMD News
$ABMD http://stks.co/3zYG volume selloff.shorting now with stop 22 .. looking for break of march support
about 2 days ago by Fernandinho
about 2 days ago by Fernandinho
$ABMD Mentioned more than normal on StockTwits - Currently at 8 x average daily social activity
about 2 days ago by TradeIdeasQuant
about 2 days ago by TradeIdeasQuant
$ABMD Prophylactic Use of Impella Achieves Cost-Effective Threshold w 58% reduction in hospitalization. http://stks.co/3zUN
about 2 days ago by abubnic
about 2 days ago by abubnic
$ABMD $ABMD Reimburse. issues will be resolved. Tiny heart pump is cost-effective, saves lives. Long-term position. http://stks.co/3zU6
about 2 days ago by abubnic
about 2 days ago by abubnic
$ABMD Shock patients using Impella 5.0 pump before revascularization: 65% higher survival rate.
about 2 days ago by abubnic
about 2 days ago by abubnic
$ABMD Impella 5.0 catheter-based pump: 56% decrease in adverse events, 58% decrease in Class III and IV heart failure.
about 2 days ago by abubnic
about 2 days ago by abubnic
$ABMD down after Lazard analyst's downgrade from Buy to Neutral, based on rehashed concerns regarding reimbursement. Buying opp.
about 2 days ago by abubnic
about 2 days ago by abubnic
Notable Analyst Rating Changes 05/22: (MTW) (GPS) (REXX) Upgraded; (ABMD) (CBE) (LOW) Downgraded
May 22, 11:10AM Street Insider
May 22, 11:10AM Street Insider
$ABMD is 6.6% up since open on unusual high volume and 7.4% up since close.
about 10 days ago by TradeBot
about 10 days ago by TradeBot
UPDATE: Wunderlich Securities Raises PT to $29 on Abiomed; Impella Exceeds Expectations
May 17, 7:31AM Benzinga
May 17, 7:31AM Benzinga
SINA Corporation, Darden Restaurants Included in Stocks Up on High Volume Wednesday
May 16, 12:35PM Fox Business
May 16, 12:35PM Fox Business
News related to $ABMD, currently -5.6% since open: 'Abiomed posts 4Q profit; shares rise on outlook' http://stks.co/3r9p
about 11 days ago by TradeBot
about 11 days ago by TradeBot
$ABMD is -5.1% down since open on unusual high volume but still 3.4% up since close.
about 11 days ago by TradeBot
about 11 days ago by TradeBot
$ABMD finally gaining some momentum w good earnings report/strong forecast. Sees Impella Revenue up 30% in 2013. http://stks.co/3r1h
about 11 days ago by abubnic
about 11 days ago by abubnic
Listen to $ABMD Q4 2012 earnings call - live at 08:00 AM, ondemand after - http://stks.co/3qhz
about 11 days ago by earningscast
about 11 days ago by earningscast
$ABMD will begin early commercial roll-out of Impella cVAD w European physicians at the EuroPCR in Paris on May 15-18. http://stks.co/3nVP
about 15 days ago by abubnic
about 15 days ago by abubnic
Abiomed to Present at Bank of America Merrill Lynch 2012 Health Care Conference
May 10, 8:00AM GlobeNewswire
May 10, 8:00AM GlobeNewswire
Abiomed Announces Participation in Three Upcoming Physician Society Meetings: SCAI, HRS, & EuroPCR
May 08, 4:02PM GlobeNewswire
May 08, 4:02PM GlobeNewswire
Abiomed Fourth Quarter and Full Fiscal Year 2012 Earnings and Conference Call Notification
May 08, 8:00AM GlobeNewswire
May 08, 8:00AM GlobeNewswire
$ABMD CEO presents at the Deutsche Bank Healthcare
Conference on May 8. http://stks.co/3gLI
about 23 days ago by abubnic
about 23 days ago by abubnic
Tiny $ABMD heart pump saves Covington woman's life. http://stks.co/3ZaD
about 27 days ago by abubnic
about 27 days ago by abubnic
Jeffries boosted target price for $ABMD this week to $28 on growth prospects, citing convergence of positive factors. http://stks.co/3ZaC
about 27 days ago by abubnic
about 27 days ago by abubnic
Rival heart pump makers $ABMD and $THOR get a boost after FDA panel recommends HeartWare's HVAD device for approval. http://stks.co/3YBD
about 30 days ago by abubnic
about 30 days ago by abubnic
Can Heart Pump Stocks Pump Up Your Portfolio? Heart pump stocks $HRWR $THOR & $ABMD have plenty of potential customers. http://stks.co/3TiE
about 33 days ago by abubnic
about 33 days ago by abubnic
$ABMD http://stks.co/3TON @BenCBanks yes it has that Dollar range over 22.50
about 33 days ago by StockTiger
about 33 days ago by StockTiger
@1nvestor I agree with $ABMD - with this short interest we could really see a pop in coming days/weeks if we break the spprt.
about 33 days ago by BenCBanks
about 33 days ago by BenCBanks
Wedge formed abv B/O level. Now back over 50d. RSI ^ $ABMD http://chart.ly/lx3k2nl
about 33 days ago by 1nvestor
about 33 days ago by 1nvestor
Abiomed Appoints Susan Vissers Lisa as Senior Director of Investor Relations and Corporate Development
Mar 21, 8:00AM Business Wire
Mar 21, 8:00AM Business Wire
Abiomed Announces Schedule of Events at American College of Cardiology 2012 Scientific Sessions
Mar 20, 8:00AM Business Wire
Mar 20, 8:00AM Business Wire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ABMD | 20.80 | -1.12 | -5.11% | 810.99M |
| ABM | 21.73 | +0.05 | +0.23% | 1.159B |
| ABIO | 0.69 | +0.14 | +25.45% | 7.259M |
| ABH | 11.83 | +0.00 | +0.00% | 1.149B |
| ABFS | 12.99 | +0.15 | +1.17% | 330.60M |
| ABD | 9.40 | -0.08 | -0.84% | 523.11M |
| ACHN | 7.35 | +0.03 | +0.41% | 518.69M |
| ACH | 10.07 | -0.25 | -2.42% | 1.589B |
| ACGL | 38.31 | -0.31 | -0.80% | 5.188B |
| ACG | 8.20 | +0.00 | +0.00% |